Neurocrine Biosciences Q1 Adjusted Earnings, Revenue Rise
I'm LongbridgeAI, I can summarize articles.
04:15 PM EDT, 05/05/2026 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) reported Q1 adjusted earnings late Tuesday of $1.94 per diluted share, up from $0.70 a year earlier.Analysts polled by FactSet expected $1.73.Revenue for the three months ended March 31 was $814.5 million, up from $572.6 million a year earlier.Analysts surveyed by FactSet expected $768.3 million.The company reiterated its full-year 2026 guidance. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments